18824712

Source:http://linkedlifedata.com/resource/pubmed/id/18824712

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006118, umls-concept:C0006826, umls-concept:C0017638, umls-concept:C0029237, umls-concept:C0030705, umls-concept:C0034897, umls-concept:C0035168, umls-concept:C0087111, umls-concept:C0239307, umls-concept:C0282460, umls-concept:C0935989, umls-concept:C1257890, umls-concept:C1868671, umls-concept:C2603343
pubmed:issue	28
pubmed:dateCreated	2008-9-30
pubmed:abstractText	To evaluate the safety and the efficacy of imatinib in recurrent malignant gliomas.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/5U10 CA11488-32, http://linkedlifedata.com/resource/pubmed/grant/5U10 CA11488-33, http://linkedlifedata.com/resource/pubmed/grant/5U10 CA11488-34
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/18824712-10468613, http://linkedlifedata.com/resource/pubmed/commentcorrection/18824712-10561324, http://linkedlifedata.com/resource/pubmed/commentcorrection/18824712-10850862, http://linkedlifedata.com/resource/pubmed/commentcorrection/18824712-11250151, http://linkedlifedata.com/resource/pubmed/commentcorrection/18824712-11287972, http://linkedlifedata.com/resource/pubmed/commentcorrection/18824712-11322447, http://linkedlifedata.com/resource/pubmed/commentcorrection/18824712-11485986, http://linkedlifedata.com/resource/pubmed/commentcorrection/18824712-12075748, http://linkedlifedata.com/resource/pubmed/commentcorrection/18824712-12091065, http://linkedlifedata.com/resource/pubmed/commentcorrection/18824712-12604685, http://linkedlifedata.com/resource/pubmed/commentcorrection/18824712-12957454, http://linkedlifedata.com/resource/pubmed/commentcorrection/18824712-14630677, http://linkedlifedata.com/resource/pubmed/commentcorrection/18824712-16033874, http://linkedlifedata.com/resource/pubmed/commentcorrection/18824712-16505440, http://linkedlifedata.com/resource/pubmed/commentcorrection/18824712-16547494, http://linkedlifedata.com/resource/pubmed/commentcorrection/18824712-16890580, http://linkedlifedata.com/resource/pubmed/commentcorrection/18824712-16914578, http://linkedlifedata.com/resource/pubmed/commentcorrection/18824712-17222792, http://linkedlifedata.com/resource/pubmed/commentcorrection/18824712-17293590, http://linkedlifedata.com/resource/pubmed/commentcorrection/18824712-17312388, http://linkedlifedata.com/resource/pubmed/commentcorrection/18824712-17317837, http://linkedlifedata.com/resource/pubmed/commentcorrection/18824712-2358840, http://linkedlifedata.com/resource/pubmed/commentcorrection/18824712-6304520, http://linkedlifedata.com/resource/pubmed/commentcorrection/18824712-7082756, http://linkedlifedata.com/resource/pubmed/commentcorrection/18824712-7829210, http://linkedlifedata.com/resource/pubmed/commentcorrection/18824712-8106574, http://linkedlifedata.com/resource/pubmed/commentcorrection/18824712-8548759, http://linkedlifedata.com/resource/pubmed/commentcorrection/18824712-9482185, http://linkedlifedata.com/resource/pubmed/commentcorrection/18824712-9815748
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Piperazines, http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines, http://linkedlifedata.com/resource/pubmed/chemical/imatinib
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	1527-7755
pubmed:author	pubmed-author:BrandesAlba AAA, pubmed-author:ClementPaul M JPM, pubmed-author:CoudertBrunoB, pubmed-author:DittrichChristianC, pubmed-author:European Organisation for Research and Treatment of Cancer Brain Tumor..., pubmed-author:FrenayMarcM, pubmed-author:FumoleauPierreP, pubmed-author:GorliaThierryT, pubmed-author:HeinrichMichael CMC, pubmed-author:KrosJohan MJM, pubmed-author:LacombeDenisD, pubmed-author:RamplingRoyR, pubmed-author:RaymondEricE, pubmed-author:StuppRogerR, pubmed-author:van den BentMartin JMJ
pubmed:issnType	Electronic
pubmed:day	1
pubmed:volume	26
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	4659-65
pubmed:dateRevised	2010-6-8
pubmed:meshHeading	pubmed-meshheading:18824712-Adult, pubmed-meshheading:18824712-Aged, pubmed-meshheading:18824712-Antineoplastic Agents, pubmed-meshheading:18824712-Brain Neoplasms, pubmed-meshheading:18824712-Disease Progression, pubmed-meshheading:18824712-Disease-Free Survival, pubmed-meshheading:18824712-Female, pubmed-meshheading:18824712-Glioma, pubmed-meshheading:18824712-Humans, pubmed-meshheading:18824712-Magnetic Resonance Imaging, pubmed-meshheading:18824712-Male, pubmed-meshheading:18824712-Middle Aged, pubmed-meshheading:18824712-Neoplasm Recurrence, Local, pubmed-meshheading:18824712-Piperazines, pubmed-meshheading:18824712-Pyrimidines, pubmed-meshheading:18824712-Statistics, Nonparametric, pubmed-meshheading:18824712-Treatment Outcome
pubmed:year	2008
pubmed:articleTitle	Phase II study of imatinib in patients with recurrent gliomas of various histologies: a European Organisation for Research and Treatment of Cancer Brain Tumor Group Study.
pubmed:affiliation	Service Inter Hospitalier de Cancérologie, Beaujon University Hospital, Clichy.
pubmed:publicationType	Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase II, Research Support, N.I.H., Extramural